Almac Sciences places £1⁄4million order for SSI TROPOS ERP solution

• New system to support the continued rapid expansion of Almac Sciences
  

LONDON - 9th October, 2006 - SSI, a Chelford Group company and provider of ERP and supply chain management solutions for specialist industries, has announced a major £1/4 million order for its TROPOS ERP solution, from Almac Sciences, a leading provider of custom synthesis services and products to the pharmaceutical industry. Almac Sciences has ordered the TROPOS end-to-end ERP and Supply Chain solution - with project accounting and project management modules that will enhance its purchasing and inventory control, and support the end-to-end supply chain solutions within its rapidly expanding cGMP manufacturing business.

Almac Sciences ordered SSI TROPOS following a full internal review of its processes. TROPOS provides Almac Sciences with purchasing control over the entire supply management cycle for all its products and services, full inventory management over its 'lean' discrete production manufacturing, and integrated quality control that will help ensure compliance with FDA regulations, HM Customs and Excise and other industry specific regulatory authorities. TROPOS also has full cost tracking through the business processes, so that it can seamlessly integrate with Almac Sciences’ existing Oracle Financials solution.

“Our previous methods for purchasing and inventory control could no longer support our rapidly expanding manufacturing business, so we needed a fully integrated, powerful system that could give us total control over our entire operation,” commented Paul McQuillan, Financial Controller, Almac Sciences. “Through SSI TROPOS we have that control, enabling us to enhance and develop the standards that we work to.

“We’re winning more customers and synthesising more products all the time, so we needed a solution that would not only give us visibility and control over our process, but one that is really aligned to the demands of our industry. We have specific regulations to adhere to, as well as internal quality control that must go on, and SSI proved through its TROPOS solution and its consultancy expertise that it really knows the pharmaceuticals industry,” he continued.

SSI TROPOS will provide Almac Sciences with the unique combination of software, technology, experience, services and future-proofing that will help ensure a seamless transition to greater and enhanced automation of purchasing and supply chain management. Additional modules ordered by Almac Sciences include TROPOS Active for event triggered workflow, TROPOS Form for document printing and TROPOS Application Designer which allows Almac Sciences to enhance and extend the system without affecting the software integrity.

“Companies in the pharmaceutical industry - as well as other regulated manufacturing sectors - are constantly realising the boundaries that paper-based processes create for their businesses,” added Neville Merritt, Group Sales and Marketing Director, Chelford Group. “Through SSI TROPOS, which integrates compliance requirements and control with business process management, expanding businesses such as Almac Sciences can become more efficient throughout the supply chain process. This has tremendous benefits for the business and helps achieve rapid ROI.”

<sub>About Almac Sciences
Almac Sciences, formed in 1992, is one of five divisions within the ALMAC Group, operating across drug discovery, API manufacture, clinical trials and drug product manufacture. The group has facilities in the US, London and Northern Ireland.

The main portfolio of Almac Sciences technologies and services includes: Contract R&D (at lab-pilot plant scales), custom manufacturing - including process development, scale-up, validation, multi tonne scale cGMP manufacture; analytical services; synthesis of cytotoxics; peptide, protein and oligo synthesis; chiral manufacturing and isotopic labelling.

ALMAC activities by division are: diagnostics (Almac Diagnostics); API contract research and manufacture (Almac Sciences); clinical supplies packaging, distribution and management (Almac Clinical Services); control and management of clinical trials (Almac Clinical Technologies) and formulation, development and commercial scale manufacture and packaging of finished pharmaceuticals (Almac Pharma Services).

About SSI
SSI specialises in the implementation and lifecycle support of web-optimised manufacturing and supply chain solutions for highly regulated process industries and 'lean' discrete manufacturers.

SSI is the developer of the class-leading TROPOS(tm) ERP solution, selected by many companies in the pharmaceuticals, food and drink, chemicals, and mill based manufacturing sectors. 'Lean' discrete manufacturers also benefit from significantly reduced lead times by using the TROPOS demand-pull model.

SSI offers end-to-end supply chain solutions including inventory optimisation, advanced planning, data collection systems and business intelligence solutions.

To complement its application solutions, SSI provides all the services required for lifecycle support with a single point of responsibility: project management, application implementation support, hosted application services, hosted web collaboration, remote managed services, bespoke systems development, systems integration, web development and technical consultancy.

Since 1982, SSI has been providing competitive advantage to a client base operating in the mid market, including small companies and subsidiaries of multinationals and large independent companies: Allergy Therapeutics, Scottish Blood Transfusion Services, Shell, Adams Pork Products, Uniq, Brintons Carpets, G&J Greenall, Fox's Confectionery, Rangemaster, Saxbys, Inter Link Foods, Tullis Russell, Turtle Wax and CWV (formerly Vymura). Recent wins include Naturally Best and Dairy Farmers of Britain.

SSI is part of the AIM-quoted Chelford Group (CHR).

Neville Merritt
Group Sales and Marketing Director
SSI
01256 685296
Neville.Merritt@ssi-world.com

Duncan Burford
The Press Office, PR for SSI
Tel: 01780 721433
dburford.pressoffice@targetwire.com


PO105 - 06</sub>
 
 

Issuers of news releases, not Targetwire, are solely responsible for the accuracy of the content.